D.E. Shaw & Co’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $28M | Buy |
200,919
+8,214
| +4% | +$1.15M | 0.02% | 945 |
|
|
2025
Q4 | $23.7M | Sell |
192,705
-221,057
| -53% | -$26.9M | 0.01% | 1148 |
|
|
2025
Q3 | $45.9M | Sell |
413,762
-286,466
| -41% | -$32.6M | 0.03% | 700 |
|
|
2025
Q2 | $77.6M | Buy |
700,228
+246,472
| +54% | +$26.2M | 0.06% | 402 |
|
|
2025
Q1 | $50.8M | Sell |
453,756
-558,706
| -55% | -$57.6M | 0.05% | 475 |
|
|
2024
Q4 | $93.5M | Buy |
1,012,462
+271,261
| +37% | +$24.4M | 0.07% | 344 |
|
|
2024
Q3 | $62.1M | Sell |
741,201
-2,597,051
| -78% | -$198M | 0.05% | 429 |
|
|
2024
Q2 | $229M | Buy |
3,338,252
+2,203,342
| +194% | +$147M | 0.21% | 97 |
|
|
2024
Q1 | $83.1M | Buy |
1,134,910
+178,269
| +19% | +$13.7M | 0.07% | 314 |
|
|
2023
Q4 | $77.5M | Sell |
956,641
-1,373,449
| -59% | -$107M | 0.07% | 339 |
|
|
2023
Q3 | $175M | Buy |
2,330,090
+279,963
| +14% | +$21.5M | 0.18% | 114 |
|
|
2023
Q2 | $158M | Buy |
2,050,127
+212,149
| +12% | +$16.9M | 0.16% | 136 |
|
|
2023
Q1 | $152M | Sell |
1,837,978
-178,062
| -9% | -$14.7M | 0.16% | 121 |
|
|
2022
Q4 | $173M | Buy |
2,016,040
+1,563,996
| +346% | +$124M | 0.19% | 94 |
|
|
2022
Q3 | $27.9M | Sell |
452,044
-1,319,616
| -74% | -$83.2M | 0.03% | 666 |
|
|
2022
Q2 | $110M | Sell |
1,771,660
-3,373,926
| -66% | -$209M | 0.13% | 164 |
|
|
2022
Q1 | $306M | Buy |
5,145,586
+4,454,256
| +644% | +$285M | 0.29% | 43 |
|
|
2021
Q4 | $50.2M | Buy |
+691,330
| New | +$47.6M | 0.04% | 545 |
|
|
2021
Q2 | – | Sell |
-609,167
| Closed | -$40.7M | – | 4841 |
|
|
2021
Q1 | $39.4M | Buy |
609,167
+238,201
| +64% | +$15.4M | 0.04% | 591 |
|
|
2020
Q4 | $21.6M | Buy |
370,966
+45,059
| +14% | +$2.72M | 0.02% | 923 |
|
|
2020
Q3 | $20.6M | Sell |
325,907
-104,436
| -24% | -$7.24M | 0.02% | 817 |
|
|
2020
Q2 | $33.1M | Sell |
430,343
-538,092
| -56% | -$41.2M | 0.04% | 529 |
|
|
2020
Q1 | $72.4M | Sell |
968,435
-3,881,635
| -80% | -$268M | 0.11% | 199 |
|
|
2019
Q4 | $315M | Sell |
4,850,070
-671,287
| -12% | -$43.7M | 0.36% | 36 |
|
|
2019
Q3 | $350M | Sell |
5,521,357
-662,256
| -11% | -$43.3M | 0.43% | 26 |
|
|
2019
Q2 | $418M | Sell |
6,183,613
-218,887
| -3% | -$14.4M | 0.52% | 20 |
|
|
2019
Q1 | $416M | Buy |
6,402,500
+4,014,025
| +168% | +$267M | 0.54% | 21 |
|
|
2018
Q4 | $149M | Buy |
2,388,475
+398,815
| +20% | +$27.9M | 0.21% | 97 |
|
|
2018
Q3 | $154M | Buy |
1,989,660
+759,460
| +62% | +$57.4M | 0.18% | 111 |
|
|
2018
Q2 | $87.1M | Sell |
1,230,200
-341,546
| -22% | -$24.1M | 0.11% | 209 |
|
|
2018
Q1 | $118M | Sell |
1,571,746
-114,887
| -7% | -$9.13M | 0.16% | 149 |
|
|
2017
Q4 | $121M | Sell |
1,686,633
-1,043,704
| -38% | -$79.3M | 0.17% | 144 |
|
|
2017
Q3 | $221M | Sell |
2,730,337
-4,650,759
| -63% | -$356M | 0.34% | 50 |
|
|
2017
Q2 | $522M | Buy |
7,381,096
+997,408
| +16% | +$66.4M | 0.86% | 5 |
|
|
2017
Q1 | $434M | Buy |
6,383,688
+1,754,565
| +38% | +$123M | 0.76% | 9 |
|
|
2016
Q4 | $331M | Buy |
4,629,123
+3,408,774
| +279% | +$253M | 0.56% | 16 |
|
|
2016
Q3 | $96.6M | Sell |
1,220,349
-279,549
| -19% | -$22.7M | 0.17% | 129 |
|
|
2016
Q2 | $125M | Buy |
1,499,898
+951,075
| +173% | +$84.4M | 0.23% | 92 |
|
|
2016
Q1 | $50.4M | Sell |
548,823
-3,967,623
| -88% | -$358M | 0.09% | 258 |
|
|
2015
Q4 | $457M | Sell |
4,516,446
-1,634,589
| -27% | -$170M | 0.68% | 11 |
|
|
2015
Q3 | $604M | Buy |
6,151,035
+1,759,029
| +40% | +$195M | 0.89% | 7 |
|
|
2015
Q2 | $514M | Buy |
4,392,006
+3,751,020
| +585% | +$410M | 0.77% | 10 |
|
|
2015
Q1 | $62.9M | Sell |
640,986
-1,384,903
| -68% | -$141M | 0.1% | 238 |
|
|
2014
Q4 | $191M | Sell |
2,025,889
-1,563,215
| -44% | -$162M | 0.25% | 71 |
|
|
2014
Q3 | $382M | Buy |
3,589,104
+2,273,925
| +173% | +$223M | 0.49% | 24 |
|
|
2014
Q2 | $109M | Buy |
1,315,179
+630,287
| +92% | +$49.1M | 0.15% | 140 |
|
|
2014
Q1 | $48.5M | Buy |
684,892
+229,569
| +50% | +$18M | 0.07% | 308 |
|
|
2013
Q4 | $34.2M | Buy |
455,323
+78,774
| +21% | +$5.49M | 0.05% | 439 |
|
|
2013
Q3 | $23.7M | Sell |
376,549
-210,019
| -36% | -$12.6M | 0.04% | 514 |
|
|
2013
Q2 | $30M | Buy |
+586,568
| New | +$30.6M | 0.06% | 374 |
|
Other funds holding GILD
VCM
VPM
D.E. Shaw & Co's GILD Position: Q1 2026 in Review
D.E. Shaw & Co increased its Gilead Sciences (GILD) stake by 4.3% in Q1 2026, buying an estimated $1.15M and bringing the position to 200,919 shares worth $28M. The position accounts for 0.02% of the portfolio, ranked #945.
D.E. Shaw & Co first reported a position in GILD in Q2 2013 and has held it in 50 quarters since. The position peaked at $604M in Q3 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- D.E. Shaw & Co held 200,919 shares of Gilead Sciences worth $28M as of Q1 2026.
- D.E. Shaw & Co bought 8,214 Gilead Sciences shares in Q1 2026, an estimated $1.15M.
- Gilead Sciences made up 0.02% of D.E. Shaw & Co's portfolio in Q1 2026, its #945 holding.
- D.E. Shaw & Co first reported a position in Gilead Sciences in Q2 2013 and has held it in 50 quarters since.
- D.E. Shaw & Co's Gilead Sciences position peaked at $604M in Q3 2015.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.